Trades on 2 secondary markets

CureGenetics

Cure Genetics (克睿基因) is a clinical-stage biotechnology company founded in 2016 and based in Suzhou, Jiangsu, China, developing cell and gene therapies for solid tumors and genetic diseases. Its differentiated pipeline is built on two proprietary platforms: AIMS CAR-NKT, a cell-therapy approach engin

minimal 8.8 / 100 0 APIs View provider profile →

Company Biotechnology Gene Therapy Cell Therapy Oncology Genetic Disease

CureGenetics is an API provider whose private shares are listed on 2 secondary markets: EquityZen, Nasdaq Private Market.

Where It Trades

EZ EquityZen View listing → N Nasdaq Private Market View listing →

Listing data is compiled from the public marketplace pages of Forge Global, Hiive, EquityZen, Nasdaq Private Market, and Augment. A listing indicates that a venue has published a page for this company — it is not an offer, a quote, or investment advice, and APIs.io has no affiliation with any venue.